Elevance Health, Inc. $ELV Stock Sold by Howard Capital Management LLC

Howard Capital Management LLC decreased its position in Elevance Health, Inc. (NYSE:ELV) by 77.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,315 shares of the company’s stock after selling 4,586 shares during the quarter. Howard Capital Management LLC’s holdings in Elevance Health were worth $511,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Goelzer Investment Management Inc. grew its position in Elevance Health by 2.4% during the third quarter. Goelzer Investment Management Inc. now owns 4,995 shares of the company’s stock valued at $1,942,000 after acquiring an additional 118 shares during the last quarter. Cantor Fitzgerald Investment Advisors L.P. raised its stake in shares of Elevance Health by 1.8% during the third quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 4,030 shares of the company’s stock worth $1,567,000 after acquiring an additional 70 shares in the last quarter. Activest Wealth Management raised its stake in shares of Elevance Health by 146.2% during the third quarter. Activest Wealth Management now owns 64 shares of the company’s stock worth $25,000 after acquiring an additional 38 shares in the last quarter. Triasima Portfolio Management inc. bought a new stake in shares of Elevance Health in the 3rd quarter worth approximately $436,000. Finally, Turtle Creek Wealth Advisors LLC lifted its holdings in shares of Elevance Health by 1.7% in the 3rd quarter. Turtle Creek Wealth Advisors LLC now owns 1,862 shares of the company’s stock worth $724,000 after acquiring an additional 31 shares during the last quarter. Institutional investors own 89.24% of the company’s stock.

Elevance Health Stock Performance

NYSE:ELV opened at $428.11 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.68. The firm’s fifty day simple moving average is $404.18 and its 200 day simple moving average is $385.91. The stock has a market cap of $92.84 billion, a P/E ratio of 19.03, a price-to-earnings-growth ratio of 2.23 and a beta of 0.70. Elevance Health, Inc. has a twelve month low of $274.84 and a twelve month high of $436.24.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Wednesday, July 15th. The company reported $7.45 EPS for the quarter, topping the consensus estimate of $6.21 by $1.24. Elevance Health had a net margin of 2.47% and a return on equity of 14.64%. The business had revenue of $49.83 billion during the quarter, compared to analyst estimates of $48.88 billion. During the same period in the prior year, the business earned $8.84 EPS. The company’s revenue for the quarter was up .8% on a year-over-year basis. As a group, research analysts predict that Elevance Health, Inc. will post 27.22 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ELV. TD Cowen upped their price objective on shares of Elevance Health from $400.00 to $465.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $395.00 target price on shares of Elevance Health in a report on Thursday, July 16th. Raymond James Financial set a $450.00 target price on shares of Elevance Health in a research report on Tuesday, July 7th. Barclays boosted their price target on shares of Elevance Health from $457.00 to $469.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 7th. Finally, Robert W. Baird upped their price target on shares of Elevance Health from $331.00 to $393.00 and gave the company a “neutral” rating in a research report on Thursday, July 16th. Fifteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, Elevance Health presently has a consensus rating of “Moderate Buy” and an average price target of $441.71.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a diversified health benefits company that provides health insurance and related services in the United States. Its offerings serve employers, individuals and families, as well as members of government-sponsored programs, including Medicare and Medicaid. The company provides medical, pharmacy, behavioral health and other benefits through a range of health plans and specialty products.

Elevance Health operates its health benefits businesses through a portfolio that includes Blue Cross and Blue Shield-affiliated plans and other insurance offerings.